Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Allergologie Select is Scopus-indexed (Q2, CiteScore 5.8), WoS ESCI. Published by Dustri-Verlag Dr. Karl Feistle.
Checked against the index lists dated .
ISSN 2512-8957Verify ISSN ↗
Publisher: Dustri-Verlag Dr. Karl Feistle
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 91 / 234 | 61st | Q2 |
| Immunology | 100 / 243 | 59th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 5.8.
Allergologie Select is Q2 in Immunology and Allergy (rank 91 of 234) and Q2 in Immunology (rank 100 of 243), by CiteScore 2025.
Allergologie Select is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q2 at the 61st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.926, quartile Q2, with an H-index of 15.
Allergologie Select is published by Dustri-Verlag Dr. Karl Feistle. Its ISSN is 2512-8957.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Allergologie Select has an h-index of 29 and a 2-year mean of 3.44 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q2. On 2-year citations it ranks #71 of 231 Scopus journals in Immunology and Allergy.
Allergologie Select published 17 papers in 2025; its busiest recent year was 2021 with 37. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2023–2026), authors are most often from Germany (63.6%), United States (8.1%) and Türkiye (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.